Keyphrases
United States
100%
Medicare
100%
Chronic Kidney Disease
100%
Receptor Agonist
100%
A1 Receptor
100%
Glucagon-like
100%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
100%
Sulfonylurea
53%
Clinical Factors
23%
Type 2 Diabetes Mellitus (T2DM)
15%
Medicare Fee-for-service
15%
Black Men
15%
Patient Demographics
7%
Retrospective Data
7%
Older Patients
7%
Retrospective Cohort Study
7%
Clinical Status
7%
Analytical Approach
7%
Asian Patients
7%
Demographic Factors
7%
Multinomial Logistic Regression Model
7%
Diagnostic Codes
7%
White Patients
7%
Hispanic Patients
7%
Residual Confounding
7%
Chronic Kidney Disease Stage
7%
Procedure Codes
7%
Type 2 Diabetes Diagnosis
7%
Patients with Cardiovascular Diseases
7%
Medicine and Dentistry
Chronic Kidney Disease
100%
Medicare
100%
Glucagon-Like Peptide-1 Agonist
100%
Sodium Glucose Cotransporter 2 Inhibitor
100%
Sulfonylurea Derivative
30%
Maturity Onset Diabetes of the Young
23%
Sulfonylurea
23%
Cohort Analysis
7%
Cardiovascular Disease
7%
Patient Population
7%
Retrospective Cohort Study
7%
Hyperlipidemia
7%
Logistic Regression Analysis
7%
Procedure Code
7%
Diagnosis Code
7%